Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Preface

Preface Indian J Surg Oncol (March 2017) 8(1):3 DOI 10.1007/s13193-016-0574-5 Jagdeesh N. Kulkarni Published online: 14 December 2016 Indian Association of Surgical Oncology 2016 instances e.g., advanced and indolent or refractory disease. Then, the focus needs to be shifted to converting this clinical setting of BFatal^ disease into BChronic^ disease so that pa- tient can live with it like comorbidity e.g., hyper tension and diabetes to name a few. Although this appears to be a laudable concept, for achieving this change of mindset of both physi- cian and patient is needed. Thirdly and arguably, the most important factor is the cost and ease of treatment delivery systems for significant length of time in an aging and not so affordable population. Lastly, we are seeing the amazing prog- ress by researchers and scientists in identifying the genetic prevalence and familial preponderance in the progeny. To my mind, the above mentioned challenges are becoming It gives me great pleasure in writing the preface to this BGenito - more relevant in this era for the genito urinary oncology prac- urinary Oncology^—special issue of the Indian Journal of titioners and allied medical fraternity. On the clinical front, Surgical Oncology (IJSO) since the journal is http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Indian Journal of Surgical Oncology Springer Journals

Preface

Abstract

Indian J Surg Oncol (March 2017) 8(1):3 DOI 10.1007/s13193-016-0574-5 Jagdeesh N. Kulkarni Published online: 14 December 2016 Indian Association of Surgical Oncology 2016 instances e.g., advanced and indolent or refractory disease. Then, the focus needs to be shifted to converting this clinical setting of BFatal^ disease into BChronic^ disease so that pa- tient can live with it like comorbidity e.g., hyper tension and diabetes to name a few. Although this appears to be a laudable concept, for...
Loading next page...
 
/lp/springer-journals/preface-hLFGODluFp
Publisher
Springer Journals
Copyright
2016 Indian Association of Surgical Oncology
ISSN
0975-7651
eISSN
0976-6952
DOI
10.1007/s13193-016-0574-5
Publisher site
See Article on Publisher Site

Abstract

Indian J Surg Oncol (March 2017) 8(1):3 DOI 10.1007/s13193-016-0574-5 Jagdeesh N. Kulkarni Published online: 14 December 2016 Indian Association of Surgical Oncology 2016 instances e.g., advanced and indolent or refractory disease. Then, the focus needs to be shifted to converting this clinical setting of BFatal^ disease into BChronic^ disease so that pa- tient can live with it like comorbidity e.g., hyper tension and diabetes to name a few. Although this appears to be a laudable concept, for achieving this change of mindset of both physi- cian and patient is needed. Thirdly and arguably, the most important factor is the cost and ease of treatment delivery systems for significant length of time in an aging and not so affordable population. Lastly, we are seeing the amazing prog- ress by researchers and scientists in identifying the genetic prevalence and familial preponderance in the progeny. To my mind, the above mentioned challenges are becoming It gives me great pleasure in writing the preface to this BGenito - more relevant in this era for the genito urinary oncology prac- urinary Oncology^—special issue of the Indian Journal of titioners and allied medical fraternity. On the clinical front, Surgical Oncology (IJSO) since the journal is

Journal

Indian Journal of Surgical OncologySpringer Journals

Published: Mar 1, 2017

Keywords: surgical oncology; oncology; surgery

There are no references for this article.